Hutchmed China Stock Fundamentals
HCM Stock | 276.00 6.00 2.13% |
HUTCHMED China fundamentals help investors to digest information that contributes to HUTCHMED China's financial success or failures. It also enables traders to predict the movement of HUTCHMED Stock. The fundamental analysis module provides a way to measure HUTCHMED China's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to HUTCHMED China stock.
At present, HUTCHMED China's Total Revenue is projected to increase significantly based on the last few years of reporting. The current year's Gross Profit is expected to grow to about 159.1 M, whereas Selling General Administrative is forecasted to decline to about 55.7 M. HUTCHMED | Select Account or Indicator |
HUTCHMED China Company Profit Margin Analysis
HUTCHMED China's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current HUTCHMED China Profit Margin | (0.07) % |
Most of HUTCHMED China's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, HUTCHMED China is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition |
Based on the latest financial disclosure, HUTCHMED China has a Profit Margin of -0.0687%. This is much lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The profit margin for all United Kingdom stocks is notably higher than that of the company.
HUTCHMED China Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining HUTCHMED China's current stock value. Our valuation model uses many indicators to compare HUTCHMED China value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across HUTCHMED China competition to find correlations between indicators driving HUTCHMED China's intrinsic value. More Info.HUTCHMED China is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the HUTCHMED China's earnings, one of the primary drivers of an investment's value.HUTCHMED Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses HUTCHMED China's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of HUTCHMED China could also be used in its relative valuation, which is a method of valuing HUTCHMED China by comparing valuation metrics of similar companies.HUTCHMED China is currently under evaluation in profit margin category among its peers.
HUTCHMED Fundamentals
Return On Equity | -0.0544 | ||||
Return On Asset | -0.059 | ||||
Profit Margin | (0.07) % | ||||
Operating Margin | (0.09) % | ||||
Current Valuation | 1.84 B | ||||
Shares Outstanding | 854.64 M | ||||
Shares Owned By Insiders | 38.94 % | ||||
Shares Owned By Institutions | 31.68 % | ||||
Price To Book | 4.10 X | ||||
Price To Sales | 3.86 X | ||||
Revenue | 838 M | ||||
Gross Profit | (271.59 M) | ||||
EBITDA | 26.58 M | ||||
Net Income | 101.09 M | ||||
Total Debt | 86.13 M | ||||
Book Value Per Share | 0.87 X | ||||
Cash Flow From Operations | 219.26 M | ||||
Earnings Per Share | (0.04) X | ||||
Target Price | 3.99 | ||||
Number Of Employees | 1.97 K | ||||
Beta | 0.75 | ||||
Market Capitalization | 2.36 B | ||||
Total Asset | 1.28 B | ||||
Retained Earnings | (870.87 M) | ||||
Working Capital | 693.81 M | ||||
Net Asset | 1.28 B |
About HUTCHMED China Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze HUTCHMED China's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of HUTCHMED China using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of HUTCHMED China based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Last Reported | Projected for Next Year | ||
Current Deferred Revenue | -4.3 M | -4.1 M | |
Total Revenue | 838 M | 879.9 M | |
Cost Of Revenue | 686.4 M | 720.8 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in HUTCHMED Stock
HUTCHMED China financial ratios help investors to determine whether HUTCHMED Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HUTCHMED with respect to the benefits of owning HUTCHMED China security.